{"title":"Bipolar Disorder: An Update on Recent Therapeutic Trials","authors":"P. Keck, S. McElroy, J. M. Hawkins","doi":"10.1097/01.IDT.0000395192.77327.9e","DOIUrl":null,"url":null,"abstract":"LEARNING OBJECTIVES After participating in this activity, the psychiatrist should be better able to:Evaluate the potential benefits of asenapine, paliperidone extended release, quetiapine, and ziprasidone in the treatment of bipolar disorder from new clinical trial results.Analyze the strengths and limitations of data regarding trials of tamoxifen, N-acetyl cysteine, and armodafinil in bipolar disorder.Apply the data from these new studies into evidence-based treatment of patients with bipolar disorder.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2011-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000395192.77327.9e","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000395192.77327.9e","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
LEARNING OBJECTIVES After participating in this activity, the psychiatrist should be better able to:Evaluate the potential benefits of asenapine, paliperidone extended release, quetiapine, and ziprasidone in the treatment of bipolar disorder from new clinical trial results.Analyze the strengths and limitations of data regarding trials of tamoxifen, N-acetyl cysteine, and armodafinil in bipolar disorder.Apply the data from these new studies into evidence-based treatment of patients with bipolar disorder.